Nancy Pelosi Urges Support Of $50 Billion ‘CHIPS’ Bill – Stands to Benefit Her
Discloses $8 Million Nvidia Stake
BY TYLER DURDEN
Oh, look: Nancy Pelosi is pushing legislation that stands to benefit her significantly thanks to a couple of brand new, multi-million dollar trades she has made.
Stop us if you’ve heard this one before…
This past week it hit the terminal that House Speaker Pelosi was doing a little portfolio re-jiggering, including exercising $8 million of call options in Nvidia and selling Apple and Visa calls. The data was per CongressTrading.com and was reported on by Bloomberg.
The Nvidia LEAPS were bought June 3, 2021 with $100 strikes, set to expire June 17, 2022 and the position appeared to be disclosed on Thursday morning for the first time. $8 million trades seem a little odd for members of Congress to begin with, but who are we to judge?
But then, what did Speaker Pelosi do just hours after disclosing the trade, on Friday? She threw her weight behind a stalled $50 billion CHIPS PLUS bill that “would provide $52 billion in funding for semiconductor manufacturing grants and investment tax credits for the chip industry,” according to RollCall.com.
The Pelosi’s have accumulated 20,000 shares of $NVDA worth $8M+
All while a $52B CHIPS act has been stalled in Congress.
Yesterday Pelosi states, “We are determined that we will pass a bill” before congress heads to August recess.$NVDA stock jumps 4% on the news.
— Nancy Pelosi Stock Tracker (@PelosiTracker_) July 15, 2022
Pelosi said last week: “We had been working constantly on the chips bill. And we need to have the transformative nature of research and education and the rest to make us continue to be preeminent in the world. How it shapes up in the next short period of time, we’ll see. But we are determined that we will pass a bill.”
“Democrats are ‘more interested in’ a chips-plus bill than a chips-only measure,” Pelosi added, according to the Roll Call report.
Yeah…interested in that and buying super yachts. Let us guess: the unrealized gains tax won’t be supported by Pelosi until she cashes out of the market altogether, either…
(TLB) published this article from ZeroHedge as compiled and written by Tyler Durden
Header featured image (edited) credit: Pelosi/original ZH article
Emphasis added by (TLB) editors
Stay tuned to …
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.